[The behavior of uricemia during treatment with spironolactone and with other diuretics].
D000086:Acetazolamide / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D002752:Chlorthalidone / Q000627:therapeutic use; D003005:Clopamide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy*; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007674:Kidney Diseases / Q000188:drug therapy*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009941:Organomercury Compounds / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood*
D004232:Diuretics; D009941:Organomercury Compounds; D013449:Sulfonamides; D006852:Hydrochlorothiazide; D003005:Clopamide; D014527:Uric Acid; D013148:Spironolactone; D005665:Furosemide; D004976:Ethacrynic Acid; D000086:Acetazolamide; D002752:Chlorthalidone; D014223:Triamterene
Il comportamento dell'uricemia durante trattamento con spironolattone e con altri diuretici.